Home › Markets › Industrials › HXL

Hexcel Corporation (HXL)

HXL trades on NYSE in Industrials, Major Chemicals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$86.13
+1.39% on the day
Market cap
$6.5B
Mid cap
Revenue · 2025
$1.9B
-0.5% on 2024
Net income · 2025
$109.4M
5.8% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerHXL on NYSE
SectorIndustrials
IndustryMajor Chemicals
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000717605
SEC industry codePlastic Materials, Synth Resins & Nonvulcan Elastomers
Incorporated inDE

Financials · 2025

LineValue
Revenue$1.9B
Net income$109.4M
Operating income$171.6M
Net margin5.8%
Operating margin9.1%
Revenue growth-0.5%
Cash$71.0M
Total assets$2.7B
P/E (computed)59.5×
P/S (computed)3.4×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B22026-04-29
Latest annual report10-K2026-02-11
Latest quarterly / interim10-Q2026-07-29
Latest current report8-K2026-07-29
Latest proxyDEFA14A2026-05-08

Source: SEC EDGAR submissions feed, 1,004 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+4.6%
1 month-4.0%
3 months-13.7%
Year to date+18.7%
1 year+40.6%
From 52-week high-20.4%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Major Chemicals

TickerCompanyPriceDayMarket cap
EMNEastman Chemical Company$63.00+1.45%$7.2B
SXTSensient Technologies Corporation$132.55+1.97%$5.6B
BCPCBalchem Corporation$169.72+0.91%$5.4B
WLKWestlake Corporation$61.86+0.02%$7.9B
NEUNewMarket Corp$898.98+0.29%$8.3B
CECelanese Corporation$44.73+0.38%$4.9B
MEOHMethanex Corporation$63.12+2.45%$4.9B
ESIElement Solutions Inc.$37.20+2.06%$9.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier